(1)
Rahmani, T. P.; Harahap, Y.; Purwanto, D. J. A Review of the Relationship Between Doxorubicin and Doxorubicinol, CBR1 Polymorphism, and Cardiotoxicity. Pharm Educ 2024, 24, p. 105-115.